(Date:11/29/2009)... CHICAGO, Nov. 29 At the 95th...iological Society of North America (RSNA) from Nov...go , Siemens Healthcare will introduce its compre...cology at booth #825, East Building/Lakeside Cen...procedures for cancer therapy, the interventio...
(Date:11/29/2009)...CHICAGO, Nov. 29 At the 95th Scie...ical Society of North America (RSNA), "Images, my ...re booth (#825) from November 29 to December 3 at ...e Center, Hall D) in Chicago. This year,s booth di...iemens support for its customers to generate, proc...
(Date:11/29/2009)..., CHICAGO, Nov. 29 Royal Philips E...sponse to an industry need by showing its portfoli... this year,s 95th annual meeting of the Radiologic...w this year from Philips are several advancements ...ng dose radiation and streamlining workflow to exp...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 1GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 2GettingHired Announces Additional Funding for Continued Growth as Well as R 26amp 3BD of New Product for Long Term Disability and Workers Comp 61669 3Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 61666 1Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 61666 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2...RE)--Jun 6, 2007 - Gilead,Sciences, Inc. (Nasdaq:G...linical trial evaluating the company,s once-daily,...e or tenofovir,DF) 300 mg as a potential treatment...t its primary efficacy endpoint. The study shows,t...aily antiviral,drug Hepsera(R) (adefovir dipivoxil...
...ux - , Waltham, Mass., June 7, 2007 – Dynoge...of its randomized, double-blind,placebo-controlle...flux disease (GERD). The study was designed to de...nt for nocturnal GERD,(NGERD). The 0.5 mg dose o...acebo on the primary endpoint of reduction in,the ...
Other Medicine Technology:Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3(Date:11/29/2009)...., Nov. 29 Acuo Technologies, deve...t software, data migration tools and services, tod...re that allows image sharing across the networks o...cuoShare solution is based on the versatile Acuo T... Acuo AcuoShare enables secure access from various...
(Date:11/29/2009)...aditional healthcare,s uncertain future and rising...tive care. Affordable Acupuncture Scottsdale answe...vember 29, 2009 -- Affordable Acupuncture, LLC ope...has been met with enthusiasm and gratitude. Its in...buted to two things, need and cost. "As far ...
(Date:11/28/2009)...ift spirits, recognize signs of depression , ...any seniors, the holiday season can trigger melanc... with health issues or worry about money problems,..., To help overcome the seasonal blues, the AGS Fou...dvice: , Get out and socialize or invite family ...
(Date:11/27/2009)...v. 27 The Gymboree Corpo...rt, CFO/COO, will present at the NASDAQ OMX 23rd I...r Hotel in London, England, on Wednesday, December...live broadcast of The Gymboree Corporation,s prese...mboree.com, click on "Our Company" at the bottom o...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
Breaking Medicine News(10 mins):Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2...nd patients started using preventive medicines mor...ring lower drug co-payments to people with diabet... could increase use of preventive medicines, sugge...erican employers cope with the rising costs of hea...
...TER, Minn. -- A new Mayo Clinic study suggests tha... with small kidney tumors may lead to decreased ov...oves the tumor but leaves the kidney intact. The s...ng with the adrenal gland that sits atop the kidne...
...., Jan. 8 ViroPharma Incorporated,(Nasdaq: VPHM ...ion to the,U.S. Food and Drug Administration (FDA)...apsules)., As part of the company,s continuing ef...ution bioequivalence,method proposed by OGD, as we...
...A. Woertz Appointed to Board of Directors, CINCIN...NYSE: PG ) today announced the appointment of Pat... officer of Archer Daniels Midland,Corporation (NY... http://www.newscom.com/cgi-bin/prnh/20080108/CLTU...
...ses on diverse set of M&A, private equity, public ...inance deals in 2007;, Irell represents leading ...alth care, aviation, communications technology and...lued at more than $7 billion., The firm advised o...
... Jan. 8 Bristol-Myers Squibb Company,(NYSE: BMY ...quity firm,announced today that Avista has complet... Imaging, a business unit of Bristol-Myers Squibb....procedures., Based in Billerica, Massachusetts, B...
Other Medicine News:Health News:Lowering Co-Pays on Some Drugs Help Fight Chronic Diseases 2Health News:How less can be more when treating some kidney cancers 2Health News:ViroPharma Provides Update on Vancocin(R) 2Health News:ViroPharma Provides Update on Vancocin(R) 3Health News:ViroPharma Provides Update on Vancocin(R) 4Health News:Procter & Gamble Announces Appointment of Director 2Health News:Irell & Manella Posts Strong Year for Corporate Transactions 2Health News:Irell & Manella Posts Strong Year for Corporate Transactions 3Health News:Irell & Manella Posts Strong Year for Corporate Transactions 4Health News:Irell & Manella Posts Strong Year for Corporate Transactions 5Health News:Irell & Manella Posts Strong Year for Corporate Transactions 6Health News:Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging 2...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: